8k insight evaluation software (Biacore)
86
Structured Review
Biacore
8k insight evaluation software
8k Insight Evaluation Software, supplied by Biacore, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/8k+insight+evaluation+software/8k+biacore+evaluation+software/pmc12710884-204-7-6
Average 86 stars, based on 1 article reviews
8k Insight Evaluation Software, supplied by Biacore, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/8k+insight+evaluation+software/8k+biacore+evaluation+software/pmc12710884-204-7-6
Average 86 stars, based on 1 article reviews
8k insight evaluation software - by Bioz Stars,
2026-09
86/100 stars
Images
Related Articles
Software:Article Title: Rapid expression of therapeutic antibodies in mammalian cells via mRNA transfection. Article Snippet: .. Sample concentrations were calculated using the Biacore Article Title: Relaxin analogs and methods of using the same Article Snippet: .. The resulting sensorgrams are analyzed using Biacore Article Title: Synergistic Inhibition Guided Fragment-Linking Strategy and Quantitative Structure–Property Relationship Modeling To Design Inhalable Therapeutics for Asthma Targeting CSF1R Article Snippet: .. The Biacore Article Title: Rapid expression of therapeutic antibodies in mammalian cells via mRNA transfection Article Snippet: .. Sample concentrations were calculated using the Biacore Article Title: Discovery of the First-in-Class Agonist-Based SOS1 PROTACs Effective in Human Cancer Cells Harboring Various KRAS Mutations. Article Snippet: Regulating SOS1 functions may result in targeted pan-KRAS therapies.. Small-molecule SOS1 inhibitors showed promising anticancer potential, and the most advanced inhibitor BI 1701963 is currently under phase I clinical studies.. SOS1 agonists provide new opportunities to treat cancer; however, the underlying mechanisms still warrant investigation. Article Title: Development of a long-acting relaxin analogue, LY3540378, for treatment of chronic heart failure. Article Snippet: Petra Verdino | Stacey L. Lee | Fariba N. Cooper | Steven R. Cottle | Patrick F. Grealish | Charlie C. Hu | Catalina M. Meyer | Joanne Lin | Victoria Copeland | Gina Porter | Richard L. Schroeder | Tyran D. Thompson | Leah L. Porras | Asim Dey | Hong Y. Zhang | Emily C. Beebe | Scot J. Matkovich | Tamer Coskun | Aldona M. Balciunas | Andrea Ferrante | Robert Siegel | Laurent Malherbe | Nicoletta Bivi | Chad D. Paavola | Ryan J. Hansen | Matthew M. Abernathy | Sylvia O. Nwosu | Molly C. Carr | Josef G. Heuer | Xiaojun Wang Article Title: A structure-based engineering approach to abrogate pre-existing antibody binding to biotherapeutics. Article Snippet: .. The resulting sensorgrams were analyzed using Biacore Article Title: DNA-Encoded Library Screen Identifies Novel Series of Respiratory Syncytial Virus Polymerase Inhibitors. Article Snippet: Respiratory syncytial virus (RSV) remains a public health burden due to unmet therapeutic needs.. We recently reported the discovery of a non-nucleoside inhibitor of the RSV polymerase and characterized its binding to a novel pocket within the capping domain of the polymerase.. Here, we describe our strategy to diversify the chemical matter targeting this site by screening our DNA-encoded chemical libraries, leading to the discovery of a novel and potent series of molecules that inhibits RSV polymerase’s biochemical activity, as well as its viral replication in cells. Binding Assay:Article Title: Relaxin analogs and methods of using the same Article Snippet: .. The resulting sensorgrams are analyzed using Biacore Article Title: Development of a long-acting relaxin analogue, LY3540378, for treatment of chronic heart failure. Article Snippet: Petra Verdino | Stacey L. Lee | Fariba N. Cooper | Steven R. Cottle | Patrick F. Grealish | Charlie C. Hu | Catalina M. Meyer | Joanne Lin | Victoria Copeland | Gina Porter | Richard L. Schroeder | Tyran D. Thompson | Leah L. Porras | Asim Dey | Hong Y. Zhang | Emily C. Beebe | Scot J. Matkovich | Tamer Coskun | Aldona M. Balciunas | Andrea Ferrante | Robert Siegel | Laurent Malherbe | Nicoletta Bivi | Chad D. Paavola | Ryan J. Hansen | Matthew M. Abernathy | Sylvia O. Nwosu | Molly C. Carr | Josef G. Heuer | Xiaojun Wang Article Title: A structure-based engineering approach to abrogate pre-existing antibody binding to biotherapeutics. Article Snippet: .. The resulting sensorgrams were analyzed using Biacore Article Title: DNA-Encoded Library Screen Identifies Novel Series of Respiratory Syncytial Virus Polymerase Inhibitors. Article Snippet: Respiratory syncytial virus (RSV) remains a public health burden due to unmet therapeutic needs.. We recently reported the discovery of a non-nucleoside inhibitor of the RSV polymerase and characterized its binding to a novel pocket within the capping domain of the polymerase.. Here, we describe our strategy to diversify the chemical matter targeting this site by screening our DNA-encoded chemical libraries, leading to the discovery of a novel and potent series of molecules that inhibits RSV polymerase’s biochemical activity, as well as its viral replication in cells. Injection:Article Title: Development of a long-acting relaxin analogue, LY3540378, for treatment of chronic heart failure. Article Snippet: Petra Verdino | Stacey L. Lee | Fariba N. Cooper | Steven R. Cottle | Patrick F. Grealish | Charlie C. Hu | Catalina M. Meyer | Joanne Lin | Victoria Copeland | Gina Porter | Richard L. Schroeder | Tyran D. Thompson | Leah L. Porras | Asim Dey | Hong Y. Zhang | Emily C. Beebe | Scot J. Matkovich | Tamer Coskun | Aldona M. Balciunas | Andrea Ferrante | Robert Siegel | Laurent Malherbe | Nicoletta Bivi | Chad D. Paavola | Ryan J. Hansen | Matthew M. Abernathy | Sylvia O. Nwosu | Molly C. Carr | Josef G. Heuer | Xiaojun Wang |